The meds they bought were toxic. Now Gambian parents seek justice.
Filing a lawsuit against the Gambian government is a rare step in one of Africa's poorest countries, where few have the means to challenge authorities.
First over-the-counter birth control pill approved by U.S. regulators
The decision widens access to the drug by removing substantial barriers to obtaining oral contraception, such as inability to get a doctor’s appointment.
Challenges persist as scandals plague Japan’s generic drug push
The aftermath of a series of manufacturing scandals is leading to shortages of the more affordable alternatives to brand-name medicine.
Eisai appoints CEO’s son to lead global Alzheimer drug program
Eisai's former global Alzheimer drug program officer, who led the push for U.S. approval of breakthrough medicine Leqembi, will retire at the end of the month.
Eisai Alzheimer's drug gets full U.S. approval, widening access to the therapy
The broader clearance from the Food and Drug Administration marks a milestone for treatment of the dementia that afflicts some 6 million Americans.
Moderna signs deal with Shanghai to make mRNA vaccines for Chinese market
The Massachusetts-based company will work with local government to conduct clinical trials and apply to bring products to market as well as to produce them in China.
Expectations grow for Alzheimer's drug in Japan, but hurdles remain
Lecanemab could be approved in the country as early as fall, but more specialist doctors and a patient screening system would be needed for widespread use.
Eli Lilly’s new weight-loss drug is even better than Ozempic
When it comes to manipulating the human metabolism, we’re entering entirely new territory with new drugs.
Japan to launch prescription-free trial sale of morning-after pill
Under current rules, women, including victims of sexual assault, must go to a clinic or hospital for a prescription to obtain an emergency contraceptive.
New Eisai and Biogen Alzheimer drug faces hurdles in Europe
Some doctors said its effect on the disease may not be clinically meaningful enough when weighed against the risk of brain swelling, its likely high price.
Japan panel weighs making morning-after pill available over the counter
Under the current policy, a visit to a medical institution and a prescription are required to purchase a morning-after pill.
U.S. takes aim at China over Latin America trade tactics and fentanyl role
China has denounced U.S. sanctions on Chinese firms and individuals over their alleged involvement in the fentanyl trade and has accused Washington of trying to deflect blame.
